利用新技术能够从少量血样中快速收集血浆
|
By LabMedica International staff writers Posted on 19 Jun 2014 |
|
图片：Noviplex Card——快速收集和分析血浆的下一代样本采集技术(图片蒙岛津科学仪器公司惠赐）。
一种“卡片实验室”采集技术现在能用一份指血样本快速生成LC-MS/MS分析等应用所需的高质量血浆。
日本京都岛津公司的子公司岛津科学仪器公司(SSI; Columbia, MD, USA)推出了下一代样本收集工具——Noviplex卡片，可加快血浆的采集和分析。这种卡片可在几分钟内用未经测量的少量全血采集一定容积的血浆样本。它非常适用于LC-MS/MS分析。Noviplex还具有独立于血细胞比容的超常的可重复性，可去除99%的红细胞，并为基于MS的分析快速制备样本，同时维持测定的可重复性和选择性。
Noviplex卡片无需静脉切开术、针筒和玻璃采集管，从而简化了血液收集。用于生成血浆的样本容积范围是20–75微升的全血。该技术为样本制备和分析物萃取提供了一步式的固相方法。它消除了冷藏、离心、溶剂萃取和蒸发等过程，加速了处理。
岛津与Novilytic实验室(Novilytic; North Webster, IN, USA/)合作推出了Noviplex卡片。普渡大学化学教授、Novilytic公司创始人之一Fred Regnier博士说：“Novilytic实验室在样本收集和制备方面的新进展大大加速了疾病标记物的分析并改变了临床化学、健康监护和医疗的规范。”SSI生命科学事业部经理Scott Kuzdzal博士说：“Noviplex技术实现了无需实验室的样本制备，方便的‘卡片实验室’格式能快速生成血浆，供LC-MS/MS分析所用。这将极大简化诊所、化验室和医院的收集和处理。”
Related Links:
岛津科学仪器公司
Noviplex卡片
Novilytic实验室
日本京都岛津公司的子公司岛津科学仪器公司(SSI; Columbia, MD, USA)推出了下一代样本收集工具——Noviplex卡片，可加快血浆的采集和分析。这种卡片可在几分钟内用未经测量的少量全血采集一定容积的血浆样本。它非常适用于LC-MS/MS分析。Noviplex还具有独立于血细胞比容的超常的可重复性，可去除99%的红细胞，并为基于MS的分析快速制备样本，同时维持测定的可重复性和选择性。
Noviplex卡片无需静脉切开术、针筒和玻璃采集管，从而简化了血液收集。用于生成血浆的样本容积范围是20–75微升的全血。该技术为样本制备和分析物萃取提供了一步式的固相方法。它消除了冷藏、离心、溶剂萃取和蒸发等过程，加速了处理。
岛津与Novilytic实验室(Novilytic; North Webster, IN, USA/)合作推出了Noviplex卡片。普渡大学化学教授、Novilytic公司创始人之一Fred Regnier博士说：“Novilytic实验室在样本收集和制备方面的新进展大大加速了疾病标记物的分析并改变了临床化学、健康监护和医疗的规范。”SSI生命科学事业部经理Scott Kuzdzal博士说：“Noviplex技术实现了无需实验室的样本制备，方便的‘卡片实验室’格式能快速生成血浆，供LC-MS/MS分析所用。这将极大简化诊所、化验室和医院的收集和处理。”
Related Links:
岛津科学仪器公司
Noviplex卡片
Novilytic实验室
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Human Estradiol Assay
Human Estradiol CLIA Kit
Latest 实验室技术 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more